Invest in IPO
(initial public offering)

Unique opportunity to invest in company shares at offering price before they start trading on the exchange
Invest in IPO
Fix Price Group Ltd*
FIXP
Anticipated price
$8.75 - $9.75

*Special terms and conditions: IPO of Fix Price Group Ltd will take place on the London Stock Exchange. Issued Global Depositary Receipts (ISIN - US33835G2057) will be also listed on the Moscow Exchange, so that the stock will be simultaneously traded on the LSE and MOEX. Once the shares are allocated to the client's account, the instrument will be quoted in Russian rubles and by closing the position (selling shares) the client will make a trade on the Moscow Exchange with settlement in rubles.

Expected pricing date: 05.03.2021
Expected trade date: 10.03.2021

Time left before the application deadline:
days
hours
minutes
seconds

How to invest in IPO

Find an IPO
Our calendar contains the latest and most relevant information on initial public offerings.
Open MT5 Global account
Thousands of instruments for investing and trading.
Transfer funds to a trading account
Instant deposit and withdrawal in many convenient ways.
Apply for an IPO in the Private Office
Preliminary position will immediately appear in the portfolio.

IPO Calendar

GROY
Gold Royalty Corp.
IPO
Anticipated date
03.03.2021
Anticipated price
$5 - $5

We are a precious metals-focused royalty and streaming company offering creative financing solutions to the metals and mining industry.

FIXP
Fix Price Group Ltd*
IPO
Anticipated date
10.03.2021
Anticipated price
$8.75 - $9.75

*Special terms and conditions: IPO of Fix Price Group Ltd will take place on the London Stock Exchange. Issued Global Depositary Receipts (ISIN - US33835G2057) will be also listed on the Moscow Exchange, so that the stock will be simultaneously traded on the LSE and MOEX. Once the shares are allocated to the client's account, the instrument will be quoted in Russian rubles and by closing the position (selling shares) the client will make a trade on the Moscow Exchange with settlement in rubles.

Expected pricing date: 05.03.2021
Expected trade date: 10.03.2021

BIGZ
BlackRock Innovation & Growth Trust
IPO
Anticipated date
26.03.2021
Anticipated price
$20 - $20

BlackRock Innovation and Growth Trust is a newly organized, non-diversified, closed-end management investment company with no operating history. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

Get analytical
overview on IPO

* Required fields

MACQU
MCAP Acquisition Corp
IPO
Anticipated date
26.02.2021
Anticipated price
$10 - $10

MCAP Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination throughout this prospectus.

FLMEU
Flame Acquisition
IPO
Anticipated date
25.02.2021
Anticipated price
$10 - $10

SPAC Offering: Flame Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.

BFRA
Biofrontera AG
Follow-on
Anticipated date
24.02.2021
Сlosing price
$8.5

FOLLOW-ON OFFERING of ADR's: We are an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin.

RFMZ
RiverNorth Flexible Municipal Income Fund II
IPO
Anticipated date
24.02.2021
Anticipated price
$20 - $20

RiverNorth Flexible Municipal Income Fund II, Inc. (the “Fund”) is a newly organized, diversified, closed-end management investment company.

BCTX
BriaCell Therapeutics
Follow-on
Anticipated date
24.02.2021
Сlosing price
$5.34

Follow-on/Uplisting: BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer, with a focus on advanced breast cancer.

AUUD
Auddia, Inc
IPO
Anticipated date
17.02.2021
Anticipated price
$4.125 - $4.125

Unit Offering Consisting of One Share of Common Stock and One Series A Warrant to Purchase One Share of Common Stock. Auddia has developed technology, utilizing Artificial Intelligence (“AI”), to enable consumers to listen to existing AM/FM radio stations without commercials. By leveraging our legacy platform that served the commercial radio industry for seven years, and by deploying new artificial (AI) technologies that can identify and segment different units of audio content, we plan to bring to market a premium, subscription-based AM/FM radio listening experience through a downloadable app called AuddiaSM (the “Auddia App”).

AMPG
AmpliTech Group
Follow-on
Anticipated date
17.02.2021
Сlosing price
$0.65

Follow-on/Uplisting Unit offering consisting of one common share and one warrant: AmpliTech Group, Inc. together with its subsidiary, Amplitech, Inc., a New York corporation “AmpliTech” or the “Company”), designs, engineers and assembles micro-wave component-based amplifiers that meet individual customer specifications.

VRPX
Virpax Pharmaceuticals
IPO
Anticipated date
17.02.2021
Anticipated price
$10 - $12

We are a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology.

AGFY
Agrify Corp
Follow-on
Anticipated date
17.02.2021
Сlosing price
$17.08

Follow-on Offering: We are a developer of highly advanced and proprietary precision hardware and software grow solutions for the indoor agriculture marketplace.

LGVN
Longeveron LLC
IPO
Anticipated date
12.02.2021
Anticipated price
$10 - $12

We are a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.

FAQ

;